Szarkóma: vizsgálatok itt: Spanyolország
40 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 11.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleA Study of Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004/KANDLELIT-004)
- Where
- Barcelona, Las Palmas de Gran Canaria, Leganés, Madrid, Málaga, Sevilla, Vic
- Életkor
- 18 év and over
- People
- 348 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT06345729 · EU 2023-507776-42-00 - 2. fázisTaking peopleKEYMAKER-U01 Substudy 01J: A Study of Pembrolizumab Plus MK-1084 in Participants With Non-Small Cell Lung Cancer (NSCLC) With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) G12C Mutations (MK-3475-01J/KEYMAKER-U01J)
- Where
- Pozuelo de Alarcón, Sevilla
- Életkor
- 18 év and over
- People
- 140 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT07252739 · EU 2025-521939-36-00 - 3. fázisTaking peopleA Study to Evaluate the Efficacy and Safety of Divarasib Compared With Investigator's Choice of Immunotherapy or Observation in Participants With Resected Stage II-III KRAS G12C-Positive Non-Small Cell Lung Cancer (NSCLC)
- Where
- A Coruña, Badalona, Barcelona, Bilbao, Granada, Lleida, Madrid, Majadahonda, Málaga, Palma, Reus, Sabadell, Santa Cruz de Tenerife, Sant Joan d'Alacant, Sevilla, Valencia, Zaragoza
- Életkor
- 18 év and over
- People
- 400 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT07541170 · EU 2025-524263-21-01 - 2. fázisTaking peopleA Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
- Where
- Barcelona, L'Hospitalet de Llobregat, Madrid
- Életkor
- 18 év and over
- People
- 111 worldwide
- Run by
- Bayer
See details and how to joinNCT06760819 · EU 2024-517419-62-00 - 2. fázisTaking peopleClinical Study in Adult and Young Adult Patients With Advanced Desmoplastic Small Round Cell Tumor (DSRCT) ISG-TULIPS
- Where
- Barcelona, Madrid, Sevilla, Zaragoza, HOSPITAL CLINICO UNIVERSITARIO VIRGEN DE LA ARRIXACA
- Életkor
- 15 év and over
- People
- 20 worldwide
- Run by
- Italian Sarcoma Group
See details and how to joinNCT07328425 · EU 2024-519261-21-00 - 1/2. fázisTaking peopleSubstudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
- Where
- Barcelona, Esplugues De Llobregat, Madrid, Valencia
- Életkor
- 6 hónap to 25 év
- People
- 90 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT06395103 · EU 2023-507178-41-00 - 1/2. fázisTaking peopleClinical trial of selinexor plus gemcitabine in selected advanced soft-tissue sarcomas
- Where
- Barcelona, Donostia, Madrid, Murcia, San Cristóbal de La Laguna, Valencia, Zaragoza
- Életkor
- 18 év and over
- People
- 88
- Run by
- Asociacion Europea Y Latinoamericana SELNET Para La Investigacion En Sarcomas
See details and how to join2024-520318-23-00 · EU 2024-520318-23-00 - 1. fázisTaking peoplePhase I Trial to Determine the Dose and Evaluate the PK and Safety of Lutetium Lu 177 Edotreotide Therapy in Pediatric Participants With SSTR-positive Tumors
- Where
- Barcelona, Madrid
- Életkor
- 24 hónap to 18 év
- People
- 20 worldwide
- Run by
- ITM Solucin GmbH
See details and how to joinNCT06441331 · EU 2024-512831-66-00 - 3. fázisTaking peopleFight Osteosarcoma Through European Research Evolving Study Platform From Diagnosis to Relapse
- Where
- Barakaldo, Barcelona, Madrid, Murcia, Santa Cruz de Tenerife, Seville, Valencia, Zaragoza
- Életkor
- 4 év and over
- People
- 530 worldwide
- Run by
- Gustave Roussy, Cancer Campus, Grand Paris
See details and how to joinNCT07871864 - 3. fázisTaking peopleSurgery With or Without Neoadjuvant Chemotherapy in High Risk RetroPeritoneal Sarcoma
- Where
- Barcelona, Madrid
- Életkor
- 18 év and over
- People
- 250 worldwide
- Run by
- European Organisation for Research and Treatment of Cancer - EORTC
See details and how to joinNCT04031677 - 1. fázisTaking peopleA Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK) and Preliminary Clinical Activity of RO7673396 in Participants With Advanced Solid Tumors Harboring Rat Sarcoma Viral Oncogene Homolog (RAS) Mutation(s)
- Where
- Barcelona, Madrid, Pamplona
- Életkor
- 18 év and over
- People
- 405 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT06884618 · EU 2024-519622-20-00 - 1/2. fázisTaking peopleA Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
- Where
- Barcelona, Esplugues De Llobregat, Madrid, Pamplona, Sevilla, Valencia
- Életkor
- Up to 25 év
- People
- 75 worldwide
- Run by
- Turning Point Therapeutics, Inc.
See details and how to joinNCT04094610 · EU 2023-506464-14-00 - 1/2. fázisTaking peopleA First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations
- Where
- Barcelona, Madrid, Pamplona, Pozuelo de Alarcón
- Életkor
- 18 év and over
- People
- 265 worldwide
- Run by
- Blueprint Medicines Corporation
See details and how to joinNCT07629960 - 4. fázisNot yet taking people in SpanyolországMulticentre, randomized, open label study comparing the concomitant administration of trabectedin and low-dose radiotherapy versus trabectedin alone in patients with advanced sarcoma
- Where
- Barcelona, Bilbao, Madrid, Oviedo, San Cristóbal de La Laguna, Sevilla, Valencia, Zaragoza
- Életkor
- 18 év and over
- People
- 80
- Run by
- Instituto De Investigacion Sanitaria Fundacion Jimenez Diaz
See details and how to join2026-525703-27-00 · EU 2026-525703-27-00 - 1. fázisTaking peopleA phase I open-label, multi-center study to evaluate the safety, tolerability, dosimetry, and preliminary activity of [177Lu]Lu-DFC413 and safety and imaging properties of [68Ga]Ga-NNS309 in patients with solid tumors
- Where
- Barcelona, L'Hospitalet de Llobregat
- Életkor
- 18 év and over
- People
- 62 worldwide
- Run by
- Novartis Pharma AG
See details and how to join2025-521702-18-00 · EU 2025-521702-18-00 - 1. fázisTaking peoplePhase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas
- Where
- Barcelona, Madrid
- Életkor
- 12 év to 85 év
- People
- 411 worldwide
- Run by
- Inhibrx Biosciences, Inc
See details and how to joinNCT03715933 · EU 2023-508139-29-00 - 1/2. fázisTaking peopleSafety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors
- Where
- Barcelona, Madrid, Málaga, Seville
- Életkor
- 18 év and over
- People
- 225 worldwide
- Run by
- Tango Therapeutics, Inc.
See details and how to joinNCT05732831 - 1/2. fázisTaking peoplePhase I-II prospective trial, multicenter, open label, exploring the combination of Trabectedin plus RAdiotherapy in Soft Tissue Sarcoma patients
- Where
- Barcelona, Madrid, Palma, San Cristóbal de La Laguna, Sevilla, Zaragoza
- Életkor
- 18 év and over
- People
- 163 worldwide
- Run by
- Asoc Grupo Espanol De Investigacion En Sarcomas
See details and how to join2024-518199-30-00 · EU 2024-518199-30-00 - 1/2. fázisTaking peopleA Phase Ib/II Study to Evaluate Safety and Efficacy of Bexmarilimab in Combination With Doxorubicin in Metastatic Soft-tissue Sarcoma.
- Where
- Badalona, Barcelona, Madrid, Málaga, San Cristóbal de La Laguna, Sevilla, Valencia, Zaragoza
- Életkor
- 18 év to 64 év
- People
- 278
- Run by
- MedSIR
See details and how to joinNCT07460986 · EU 2025-525144-18-00 - 1. fázisTaking peopleLong-Term Follow-Up (LTFU) of Participants Treated with Adoptive Cell Therapies
- Where
- Sevilla
- People
- 7 worldwide
- Run by
- USWM Ct LLC
See details and how to join2024-513033-21-00 · EU 2024-513033-21-00 - 3. fázisTaking peopleA Study to Investigate Efficacy & Safety of Intratumoral INT230-6 Compared to US Standard of Care in Adults With Soft Tissue Sarcomas (INVINCIBLE-3)
- Where
- Barcelona, Granada, L'Hospitalet de Llobregat, Madrid, Pamplona, Sevilla, Valencia
- Életkor
- 18 év and over
- People
- 333 worldwide
- Run by
- Intensity Therapeutics, Inc.
See details and how to joinNCT06263231 · EU 2024-512423-36-00 - 1. fázisTaking peopleTrial to evaluate CAR-T NKG2D CAR cell infusions in patients with advanced sarcoma
- Where
- Madrid
- Életkor
- Up to 64 év
- People
- 18
- Run by
- Hospital Universitario La Paz
See details and how to join2024-513514-35-00 · EU 2024-513514-35-00 - 2. fázisTaking peopleClinical trial of trabectedin, irinotecann and low-dose radiation therapy in advanced/metastatic sarcomas.
- Where
- Barcelona, La Laguna, Madrid, Valencia
- People
- 92
- Run by
- Asoc Grupo Espanol De Investigacion En Sarcomas
See details and how to joinNCT05131386 · EU 2023-509215-81-00 - 1/2. fázisTaking peopleStudy in Children and Adolescents of 177Lu-DOTATATE (Lutathera®) Combined With the PARP Inhibitor Olaparib for the Treatment of Recurrent or Relapsed Solid Tumours Expressing Somatostatin Receptor (SSTR) (LuPARPed).
- Where
- Boadilla del Monte
- Életkor
- 3 év and over
- People
- 25
- Run by
- Fundación de investigación HM
See details and how to joinNCT06607692 · EU 2024-512613-40-00 - 1/2. fázisTaking peopleA Study to Evaluate the Safety, Tolerability, and Efficacy of BMS-986523 Alone and in Combination With Anti-Cancer Agents in Participants With Advanced Solid Malignancies
- Where
- Badalona, Hortaleza
- Életkor
- 18 év and over
- People
- 252 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT07223047